Jaguar Health Inc（JAGX）價格預測JAGXJaguar Health Inc

Alphio's JAGX stock price prediction model matches the current Jaguar Health Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.81 (-0.36%). The 1-week path is $0.81 (-0.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Jaguar Health Inc is not a good buy right now. The current price is $0.81, and the stock has experienced a staggering year-to-date decline of 97.68%. The RSI is at 31.68, indicating that the stock is oversold, but this does not guarantee a price recovery. The forward P/E ratio is extremely high at 200, suggesting that the stock is overvalued relative to its earnings potential. Additionally, the company reported a significant net income loss of $12.7 million in Q2 2026, which raises concerns about its financial health. The main risk is the ongoing high cash burn rate and declining revenues, with a 60% year-over-year decline in prescription product net revenue in Q2 2026, which could further strain operations if not addressed promptly.

Jaguar Health Inc (JAGX) last closed at $0.8099, losing -6.37%. These facts feed the 1-day and 1-week JAGX price prediction above.